Increase in Drug Use After Admission to Dutch Nursing Homes

Overview

Journal Pharm World Sci

Publisher Springer

Specialties Pharmacology
Pharmacy

Date 2003 Mar 29

PMID 12661475

Citations 3

Authors

Raymond T C M Koopmans

Jean-Pierre van der Borgh

J Hans J Bor

Yechiel A Hekster

Affiliations

Soon will be listed here.

Abstract

Objective: To study changes in drug use after admission to Dutch nursing homes.

Setting: Six nursing homes near the city of Nijmegen, The Netherlands.

Design: Prospective longitudinal study.

Methods: All patients who had been newly admitted to the nursing home were included in the study. Age, gender, residence of the patients before admission, and indication were registered. All prescriptions were registered with start-date and end-date. The nomenclature and subcategory definitions used were those of the World Health Organisation Nordic Anatomical Therapeutic Chemical classification index (ATC) codes. Patients had a follow-up of six weeks.

Results: There was a minor, but statistically significant, increase in the mean number of drugs from 5.6 on admission to 5.8 six weeks later. Patients referred from a hospital and patients with a somatic indication were prescribed the highest number of drugs. On admission 5.5% of the patients were not on medication at all, 48% were using 1-2 drugs, and 46% had been prescribed 6 or more drugs. Six weeks after admission, a significant increase in drug use was found in drugs for the nervous system, and drugs for the sensory organs.

Conclusion: Increase in drug use does not necessarily have to reflect bad prescribing practices. However, in this frail population, continuous drug review is needed to guarantee quality of prescribing and reduce unnecessary polypharmacy.

Citing Articles

Polypharmacy in elderly hospitalised patients in Slovakia.

Wawruch M, Zikavska M, Wsolova L, Kuzelova M, Tisonova J, Gajdosik J Pharm World Sci. 2007; 30(3):235-42.

PMID: 17943457 DOI: 10.1007/s11096-007-9166-3.

Adverse drug effects in elderly people -- a disparity between clinical examination and adverse effects self-reported by the patient.

Lampela P, Hartikainen S, Sulkava R, Huupponen R Eur J Clin Pharmacol. 2007; 63(5):509-15.

PMID: 17351768 DOI: 10.1007/s00228-007-0283-7.

Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study.

Jyrkka J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H Eur J Clin Pharmacol. 2006; 62(2):151-8.

PMID: 16408226 DOI: 10.1007/s00228-005-0079-6.

References

FROOM J, Trilling J . Reducing antihypertensive medication use in nursing home patients. Arch Fam Med. 2000; 9(4):378-83. DOI: 10.1001/archfami.9.4.378. View

van Dijk K, de Vries C, van den Berg P, Brouwers J, de Jong-van den Berg L . Drug utilisation in Dutch nursing homes. Eur J Clin Pharmacol. 2000; 55(10):765-71. DOI: 10.1007/s002280050012. View

Gambassi G, Landi F, Peng L, Calore K, Hiris J, Lipsitz L . Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. Med Care. 1998; 36(2):167-79. DOI: 10.1097/00005650-199802000-00006. View

Beers M, Ouslander J, Fingold S, Morgenstern H, Reuben D, Rogers W . Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med. 1992; 117(8):684-9. DOI: 10.7326/0003-4819-117-8-684. View

van Kraaij D, Jansen R, Gribnau F, Hoefnagels W . Use of diuretics and opportunities for withdrawal in a Dutch nursing home population. Neth J Med. 1998; 53(1):20-6. DOI: 10.1016/s0300-2977(98)00053-9. View

Schmidt I, Claesson C, WESTERHOLM B, Nilsson L . Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother. 1998; 32(1):27-32. DOI: 10.1177/106002809803200102. View

OGrady M, Weedle P . A descriptive study of drug therapy and cost for elderly residents in a nursing home. Ir Med J. 1999; 91(5):172-4. View

Khunti K, KINSELLA B . Effect of systematic review of medication by general practitioner on drug consumption among nursing-home residents. Age Ageing. 2000; 29(5):451-3. DOI: 10.1093/ageing/29.5.451. View

van Dijk K, de Vries C, van den Berg P, Dijkema A, Brouwers J, de Jong-van den Berg L . Constipation as an adverse effect of drug use in nursing home patients: an overestimated risk. Br J Clin Pharmacol. 1998; 46(3):255-61. PMC: 1873685. DOI: 10.1046/j.1365-2125.1998.00777.x. View

10.

Piecoro L, Browning S, Prince T, Ranz T, Scutchfield F . A database analysis of potentially inappropriate drug use in an elderly medicaid population. Pharmacotherapy. 2000; 20(2):221-8. DOI: 10.1592/phco.20.3.221.34779. View

11.

Claesson C, Schmidt I . Drug use in Swedish nursing homes. Clin Drug Investig. 2008; 16(6):441-52. DOI: 10.2165/00044011-199816060-00004. View

12.

Gupta S, RAPPAPORT H, Bennett L . Inappropriate drug prescribing and related outcomes for elderly medicaid beneficiaries residing in nursing homes. Clin Ther. 1996; 18(1):183-96. DOI: 10.1016/s0149-2918(96)80189-5. View

13.

Wayne S, Rhyne R, Stratton M . Longitudinal prescribing patterns in a nursing home population. J Am Geriatr Soc. 1992; 40(1):53-6. DOI: 10.1111/j.1532-5415.1992.tb01829.x. View

14.

Williams B, Betley C . Inappropriate use of nonpsychotropic medications in nursing homes. J Am Geriatr Soc. 1995; 43(5):513-9. DOI: 10.1111/j.1532-5415.1995.tb06098.x. View

15.

Avorn J, Gurwitz J . Drug use in the nursing home. Ann Intern Med. 1995; 123(3):195-204. DOI: 10.7326/0003-4819-123-3-199508010-00007. View

16.

Cohen-Mansfield J, Lipson S, Werner P, Billig N, Taylor L, Woosley R . Withdrawal of haloperidol, thioridazine, and lorazepam in the nursing home: a controlled, double-blind study. Arch Intern Med. 1999; 159(15):1733-40. DOI: 10.1001/archinte.159.15.1733. View

17.

Gambassi G, Landi F, Lapane K, Sgadari A, Mor V, Bernabei R . Is drug use by the elderly with cognitive impairment influenced by type of dementia?. Pharmacotherapy. 1999; 19(4):430-6. DOI: 10.1592/phco.19.6.430.31037. View

18.

Vander Stichele R, Mestdagh J, Van Haecht C, De Potter B, Bogaert M . Medication utilization and patient information in homes for the aged. Eur J Clin Pharmacol. 1992; 43(3):319-21. DOI: 10.1007/BF02333032. View

19.

Roberts M, Stokes J, King M, Lynne T, Purdie D, Glasziou P . Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001; 51(3):257-65. PMC: 2015028. DOI: 10.1046/j.1365-2125.2001.00347.x. View

20.

Stein C, Griffin M, Taylor J, Pichert J, Brandt K, Ray W . Educational program for nursing home physicians and staff to reduce use of non-steroidal anti-inflammatory drugs among nursing home residents: a randomized controlled trial. Med Care. 2001; 39(5):436-45. DOI: 10.1097/00005650-200105000-00004. View